Metformin Regulates the miR-205/VEGFA Axis in Renal Cell Carcinoma Cells: Exploring a Clinical Synergism with Tyrosine Kinase Inhibitors.

Authors:
Krebs M; Kotlyar MJ; Fahl J; Janaki Raman S; Röhrig F and 5 more

Journal:
Urol Int

Publication Year: 2023

DOI:
10.1159/000535025

PMCID:
PMC10836959

PMID:
38035560

Journal Information

Full Title: Urol Int

Abbreviation: Urol Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Statement The authors have no conflicts of interest to declare."

Evidence found in paper:

"M.K. was funded by a personal grant from Else-Kröner-Foundation (Else Kröner Integrative Clinician Scientist College for Translational Immunology, University Hospital Würzburg, Germany). Pfizer (New York, NY, USA) kindly provided sunitinib and axitinib."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025